Daiichi Sankyo

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daiichi Sankyo and other ETFs, options, and stocks.

About DSNKY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.

CEO

Sunao Manabe

CEOSunao Manabe

Employees

17,435

Employees17,435

Headquarters

Tokyo, Tokyo

HeadquartersTokyo, Tokyo

Founded

2005

Founded2005

Employees

17,435

Employees17,435

DSNKY Key Statistics

Market cap

69.83B

Market cap69.83B

Price-Earnings ratio

49.33

Price-Earnings ratio49.33

Dividend yield

0.44%

Dividend yield0.44%

Average volume

286.38K

Average volume286.38K

High today

$36.84

High today$36.84

Low today

$35.49

Low today$35.49

Open price

$36.84

Open price$36.84

Volume

62.92K

Volume62.92K

52 Week high

$37.57

52 Week high$37.57

52 Week low

$23.72

52 Week low$23.72

DSNKY News

Simply Wall St 1d

Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's Earnings Are - Simply Wall St

When companies post strong earnings, the stock generally performs well, just like Daiichi Sankyo Company, Limited's ( ) stock has recently. Our analysis found s...

Benzinga 5d

Double Good News For AstraZeneca's Breast Cancer Drugs - AstraZeneca, Daiichi Sankyo Co (OTC - Benzinga

Loading... Loading... AstraZeneca plc AZN reported topline data from a metastatic breast cancer treatment study. The results showed that Enhertu (trastuzumab...

Simply Wall St 6d

Daiichi Sankyo Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St

It's been a good week for Daiichi Sankyo Company, Limited ( ) shareholders, because the company has just released its latest yearly results, and the shares gain...